SUBSCRIBE
SUBSCRIBE

Merakris Therapeutics

JOBS
IN THE PRESS
Press Releases
Merakris Therapeutics Enrolls 30th Subject in Expanded Access Program of MTX-001; Highlights Clinical Progress at SAWC Fall 2025
September 4, 2025
 · 
4 min read
Press Releases
Merakris Therapeutics Receives USPTO Notice of Allowance for Foundational Patent Supporting MTX-001 Biologic Drug Platform
August 20, 2025
 · 
4 min read
Press Releases
Merakris Therapeutics Spotlights Investigational New Drug, MTX-001, with Innovation Showcase Win at 2025 Advanced Wound Care Summit
July 25, 2025
 · 
3 min read
Press Releases
Merakris Therapeutics Selected as Finalist for 2025 Advanced Wound Care Summit Innovation Showcase
July 15, 2025
 · 
3 min read
Press Releases
Merakris Therapeutics Appoints Roger Ilagan to Chief Scientific Officer
April 10, 2025
 · 
4 min read
Press Releases
Merakris Therapeutics Announces Open Enrollment for Phase II Clinical Trial of Subcutaneous Injection Drug for the Treatment of Venous Leg Ulcer
December 10, 2024
 · 
4 min read
Press Releases
Merakris Therapeutics Introduces Dermacyte® AC Matrix: A Lyophilized Amnion Chorion Allograft
October 1, 2024
 · 
3 min read
Press Releases
Merakris Therapeutics Announces FDA Clearance for Part 2 of its Phase II Multicenter Investigational New Drug Study of Dermacyte® Liquid
September 5, 2024
 · 
4 min read
Business
Jonathan Berlent Joins Merakris as SVP, Head of Strategy and Operations
May 9, 2024
 · 
3 min read
Drug Development
Merakris Therapeutics to Release Final Part 1 Data From Phase 2 Multicenter Investigational Drug Study for Dermacyte® Liquid
February 20, 2024
 · 
5 min read
Load More